Back
Speaker illustration

Doctor Natalia Paterson

Tenaya Therapeutics, South San Francisco (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association of the ESC

Presentations

Low seroprevalence of neutralizing antibodies to adeno-associated virus serotype 9 in preparation for MyPEAK-1 study of TN-201 for individuals with MYBPC3-associated hypertrophic cardiomyopathy

Event: Heart Failure 2025

Topic: Hypertrophic Cardiomyopathy

Session: Myocarditis

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources